Alzheimer's disease (AD) is the most common type of dementia. In connection with the global trend of prolonging human life and the increasing number of elderly in the population, the AD becomes one of the most serious health and socioeconomic problems of the present. Tau protein promotes assembly and stabilizes microtubules, which contributes to the proper function of neuron. Alterations in the amount or the structure of tau protein can affect its role as a stabilizer of microtubules as well as some of the processes in which it is implicated. The molecular mechanisms governing tau aggregation are mainly represented by several posttranslational modifications that alter its structure and conformational state. Hence, abnormal phosphorylation and truncation of tau protein have gained attention as key mechanisms that become tau protein in a pathological entity. Evidences about the clinicopathological significance of phosphorylated and truncated tau have been documented during the progression of AD as well as their capacity to exert cytotoxicity when expressed in cell and animal models. This paper describes the normal structure and function of tau protein and its major alterations during its pathological aggregation in AD.

Laboratory of Biochemistry and Brain Pathophysiology and AD Center Prague Psychiatric Center Ústavní 91 181 03 Prague 8 Czech Republic

Zobrazit více v PubMed

Maccioni RB, Muñoz JP, Barbeito L. The molecular bases of Alzheimer’s disease and other neurodegenerative disorders. Archives of Medical Research. 2001;32(5):367–381. PubMed

Kosik KS. The molecular and cellular biology of tau. Brain Pathology. 1993;3(1):39–43. PubMed

Mandelkow EM, Biernat J, Drewes G, Gustke N, Trinczek B, Mandelkow E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiology of Aging. 1995;16(3):355–363. PubMed

Liu F, Iqbal K, Grundke-Iqbal I, Rossie S, Gong CX. Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer’s disease. The Journal of Biological Chemistry. 2005;280(3):1790–1796. PubMed

Avila J. Tau kinases and phosphatases: commentary. Journal of Cellular and Molecular Medicine. 2008;12(1):258–259. PubMed PMC

Iqbal K, Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention: Alzheimer review series. Journal of Cellular and Molecular Medicine. 2008;12(1):38–55. PubMed PMC

Sergeant N, Delacourte A, Buée L. Tau protein as a differential biomarker of tauopathies. Biochimica et Biophysica Acta. 2005;1739(2):179–197. PubMed

Cleveland DW, Hwo SY, Kirschner MW. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. Journal of Molecular Biology. 1977;116(2):227–247. PubMed

Von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochimica et Biophysica Acta. 2005;1739(2):158–166. PubMed

Gamblin TC. Potential structure/function relationships of predicted secondary structural elements of tau. Biochimica et Biophysica Acta. 2005;1739(2):140–149. PubMed

Jeganathan S, Von Bergen M, Mandelkow EM, Mandelkow E. The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments. Biochemistry. 2008;47(40):10526–10539. PubMed

Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nature Reviews Molecular Cell Biology. 2005;6(3):197–208. PubMed

Mukrasch MD, Bibow S, Korukottu J, et al. Structural polymorphism of 441-residue Tau at single residue resolution. PLoS Biology. 2009;7(2) Article ID e1000034. PubMed PMC

Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. The EMBO Journal. 1990;9(13):4225–4230. PubMed PMC

Alonso ADC, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(12):6923–6928. PubMed PMC

Sergeant N, Bretteville A, Hamdane M, et al. Biochemistry of Tau in Alzheimer’s disease and related neurological disorders. Expert Review of Proteomics. 2008;5(2):207–224. PubMed

Ebneth A, Godemann R, Stamer K, et al. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer’s disease. Journal of Cell Biology. 1998;143(3):777–794. PubMed PMC

Couchie D, Mavilia C, Georgieff IS, Liem RKH, Shelanski ML, Nunez J. Primary structure of high molecular weight tau present in the peripheral nervous system. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(10):4378–4381. PubMed PMC

Georgieff IS, Liem RKH, Couchie D, Mavilia C, Nunez J, Shelanski ML. Expression of high molecular weight tau in the central and peripheral nervous systems. Journal of Cell Science. 1993;105(3):729–737. PubMed

Goedert M, Spillantini MG, Crowther RA. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(5):1983–1987. PubMed PMC

Balastik M, Lim J, Pastorino L, Lu KP. Pin1 in Alzheimer’s disease: multiple substrates, one regulatory mechanism? Biochimica et Biophysica Acta. 2007;1772(4):422–429. PubMed PMC

Jung D, Filliol D, Miehe M, Rendon A. Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU. Cell Motility and the Cytoskeleton. 1993;24(4):245–255. PubMed

Brandt R, Léger J, Lee G. Interaction of tau with the neural plasma membrane mediated by tau’s amino-terminal projection domain. Journal of Cell Biology. 1995;131(5):1327–1340. PubMed PMC

Arrasate M, Pérez M, Avila J. Tau dephosphorylation at Tau-1 site correlates with its association to cell membrane. Neurochemical Research. 2000;25(1):43–50. PubMed

Maas T, Eidenmüller J, Brandt R. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. The Journal of Biological Chemistry. 2000;275(21):15733–15740. PubMed

Reynolds CH, Garwood CJ, Wray S, et al. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cγ1, Grb2, and Src family kinases. The Journal of Biological Chemistry. 2008;283(26):18177–18186. PubMed

Baba A, Akagi K, Takayanagi M, Flanagan JG, Kobayashi T, Hattori M. Fyn tyrosine kinase regulates the surface expression of glycosylphosphatidylinositol-linked ephrin via the modulation of sphingomyelin metabolism. The Journal of Biological Chemistry. 2009;284(14):9206–9214. PubMed PMC

Hoe HS, Minami SS, Makarova A, et al. Fyn modulation of Dab1 effects on amyloid precursor protein and apoe receptor 2 processing. The Journal of Biological Chemistry. 2008;283(10):6288–6299. PubMed

Lee G, Thangavel R, Sharma VM, et al. Phosphorylation of tau by fyn: implications for Alzheimer’s disease. Journal of Neuroscience. 2004;24(9):2304–2312. PubMed PMC

Pooler AM, Usardi A, Evans CJ, Philpott KL, Noble W, Hanger DP. Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiology of Aging. 2012;33(2):431.e27–431.e38. PubMed

Ittner LM, Ke YD, Delerue F, et al. Dendritic function of tau mediates amyloid-β toxicity in alzheimer’s disease mouse models. Cell. 2010;142(3):387–397. PubMed

Pritchard SM, Dolan PJ, Vitkus A, Johnson GVW. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics. Journal of Cellular and Molecular Medicine. 2011;15(8):1621–1635. PubMed PMC

Cardona-Gómez GP, Arango-Davila C, Gallego-Gómez JC, Barrera-Ocampo A, Pimienta H, Garcia-Segura LM. Estrogen dissociates Tau and alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic acid receptor subunit in postischemic hippocampus. NeuroReport. 2006;17(12):1337–1341. PubMed

Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. Journal of Neuroscience. 2002;22(3):698–707. PubMed PMC

Brandt R, Lee G. Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. The Journal of Biological Chemistry. 1993;268(5):3414–3419. PubMed

Mandell JW, Banker GA. A spatial gradient of tau protein phosphorylation in nascent axons. Journal of Neuroscience. 1996;16(18):5727–5740. PubMed PMC

Drechsel DN, Hyman AA, Cobb MH, Kirschner MW. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Molecular Biology of the Cell. 1992;3(10):1141–1154. PubMed PMC

Butner KA, Kirschner MW. Tau protein binds to microtubules through a flexible array of distributed weak sites. Journal of Cell Biology. 1991;115(3):717–730. PubMed PMC

Goode BL, Feinstein SC. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. Journal of Cell Biology. 1994;124(5):769–781. PubMed PMC

Sontag E, Nunbhakdi-Craig V, Lee G, et al. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. The Journal of Biological Chemistry. 1999;274(36):25490–25498. PubMed

Drubin DG, Nelson WJ. Origins of cell polarity. Cell. 1996;84(3):335–344. PubMed

Goodson HV, Valetti C, Kreis TE. Motors and membrane traffic. Current Opinion in Cell Biology. 1997;9(1):18–28. PubMed

Waterman-Storer CM, Salmon ED. Microtubule dynamics: treadmilling comes around again. Current Biology. 1997;7(6):R369–R372. PubMed

Brady ST, Sperry AO. Biochemical and functional diversity of microtubule motors in the nervous system. Current Opinion in Neurobiology. 1995;5(5):551–558. PubMed

Lippincott-Schwartz J, Cole NB, Marotta A, Conrad PA, Bloom GS. Kinesin is the motor for microtubule-mediated Golgi-to-ER membrane traffic. Journal of Cell Biology. 1995;128(3):293–306. PubMed PMC

Morris RL, Hollenbeck PJ. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. Journal of Cell Science. 1993;104(3):917–927. PubMed

Tanaka Y, Kanai Y, Okada Y, et al. Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell. 1998;93(7):1147–1158. PubMed

Hollenbeck PJ, Swanson JA. Radial extension of macrophage tubular lysosomes supported by kinesin. Nature. 1990;346(6287):864–866. PubMed

Wiemer EAC, Wenzel T, Deerinck TJ, Ellisman MH, Subramani S. Visualization of the peroxisomal compartment in living mammalian cells: dynamic behavior and association with microtubules. Journal of Cell Biology. 1997;136(1):71–80. PubMed PMC

Scales SJ, Pepperkok R, Kreis TE. Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPII and COPI. Cell. 1997;90(6):1137–1148. PubMed

Cuchillo-Ibanez I, Seereeram A, Byers HL, et al. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. The FASEB Journal. 2008;22(9):3186–3195. PubMed

Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. Journal of Cell Science. 1999;112(14):2355–2367. PubMed

Carrell RW, Gooptu B. Conformational changes and disease–serpins, prions and Alzheimer’s. Current Opinion in Structural Biology. 1998;8(6):799–809. PubMed

Fox N, Harvey RJ, Rossor MN. Protein folding, nucleation phenomena and delayed neurodegeneration in Alzheimer’s disease. Reviews in the Neurosciences. 1996;7(1):21–28. PubMed

Hyman BT, Augustinack JC, Ingelsson M. Transcriptional and conformational changes of the tau molecule in Alzheimer’s disease. Biochimica et Biophysica Acta. 2005;1739(2):150–157. PubMed

García-Sierra F, Ghoshal N, Quinn B, Berry RW, Bínder LI. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer’s disease. Journal of Alzheimer’s Disease. 2003;5(2):65–77. PubMed

Ghoshal N, García-Sierra F, Fu Y, et al. Tau-66: evidence for a novel tau conformation in alzheimer’s disease. Journal of Neurochemistry. 2001;77(5):1372–1385. PubMed

Ghoshal N, García-Sierra F, Wuu J, et al. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer’s disease. Experimental Neurology. 2002;177(2):475–493. PubMed

Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiology of Aging. 2003;24(8):1079–1085. PubMed

LaPointe NE, Morfini G, Pigino G, et al. The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. Journal of Neuroscience Research. 2009;87(2):440–451. PubMed PMC

Futerman AH, Banker GA. The economics of neurite outgrowth–the addition of new membrane to growing axons. Trends in Neurosciences. 1996;19(4):144–149. PubMed

Trojanowski JQ, Lee VMY. Phosphorylation of paired helical filament tau in Alzheimer’s disease neurofibrillary lesions: focusing on phosphatases. The FASEB Journal. 1995;9(15):1570–1576. PubMed

Martin L, Latypova X, Terro F. Post-translational modifications of tau protein: implications for Alzheimer’s disease. Neurochemistry International. 2011;58(4):458–471. PubMed

Soto C. Alzheimer’s and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches. Journal of Molecular Medicine. 1999;77(5):412–418. PubMed

Grundke-Iqbal I, Iqbal K, Tung YC. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences of the United States of America. 1986;83(13):44913–4917. PubMed PMC

Mondragón-Rodríguez S, Basurto-Islas G, Binder LI, García-Sierra F. Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer’s disease? Future Neurology. 2009;4(1):39–53.

Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW. Tau, tangles, and Alzheimer’s disease. Biochimica et Biophysica Acta. 2005;1739(2):216–223. PubMed

Kuhla B, Haase C, Flach K, Lüth HJ, Arendt T, Münch G. Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. The Journal of Biological Chemistry. 2007;282(10):6984–6991. PubMed

Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 1988;85(13):4884–4888. PubMed PMC

Perry G, Mulvihill P, Fried VA, Smith HT, Grundke-Iqbal I, Iqbal K. Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease. Journal of Neurochemistry. 1989;52(5):1523–1528. PubMed

Reynolds MR, Berry RW, Binder LI. Site-specific nitration and oxidative dityrosine bridging of the τ protein by peroxynitrite: implications for Alzheimer’s disease. Biochemistry. 2005;44(5):1690–1700. PubMed

Gamblin TC, Chen F, Zambrano A, et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(17):10032–10037. PubMed PMC

Min SW, Cho SH, Zhou Y, et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 2010;67(6):953–966. PubMed PMC

Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Research Reviews. 2000;33(1):95–130. PubMed

Drewes G, Trinczek B, Illenberger S, et al. Microtubule-associated protein/microtubule affinity-regulating kinase (p110(mark)). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer- specific site serine 262. The Journal of Biological Chemistry. 1995;270(13):7679–7688. PubMed

Dickey CA, Kamal A, Lundgren K, et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. The Journal of Clinical Investigation. 2007;117(3):648–658. PubMed PMC

Gong CX, Iqbal K. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Current Medicinal Chemistry. 2008;15(23):2321–2328. PubMed PMC

Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Merkle RK, Gong CX. Role of glycosylation in hyperphosphorylation of tau in Alzheimer’s disease. FEBS Letters. 2002;512(1–3):101–106. PubMed

Avila J, Lucas JJ, Pérez M, Hernández F. Role of tau protein in both physiological and pathological conditions. Physiological Reviews. 2004;84(2):361–384. PubMed

Kopke E, Tung YC, Shaikh S, Del Alonso CA, Iqbal K, Grundke-Iqbal I. Microtubule-associated protein tau. Abnormal phosphorylation of a non- paired helical filament pool in Alzheimer disease. The Journal of Biological Chemistry. 1993;268(32):24374–24384. PubMed

Iqbal K, Liu F, Gong CX, del Alonso AC, Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathologica. 2009;118(1):53–69. PubMed PMC

Khatoon S, Grundke-Iqbal I, Iqbal K. Levels of normal and abnormally phosphorylated tan in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Letters. 1994;351(1):80–84. PubMed

Alonso ADC, Zaidi T, Grundke-Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(12):5562–5566. PubMed PMC

Li B, Chohan MO, Grundke-Iqbal I, Iqbal K. Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathologica. 2007;113(5):501–511. PubMed PMC

Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. The Journal of Biological Chemistry. 1995;270(9):4854–4860. PubMed

Alonso ADC, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(1):298–303. PubMed PMC

Hanger DP, Byers HL, Wray S, et al. Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. The Journal of Biological Chemistry. 2007;282(32):23645–23654. PubMed

Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 1993;11(1):153–163. PubMed

Du JT, Yu CH, Zhou LX, et al. Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat. FEBS Journal. 2007;274(19):5012–5020. PubMed

Lee VMY, Balin BJ, Otvos L, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 1991;251(4994):675–678. PubMed

Grundke-Iqbal I, Iqbal K, Quinlan M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. The Journal of Biological Chemistry. 1986;261(13):6084–6089. PubMed

Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology. 1992;42(3):631–639. PubMed

Bancher C, Brunner C, Lassmann H, et al. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Research. 1989;477(1-2):90–99. PubMed

Braak E, Braaak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathologica. 1994;87(6):554–567. PubMed

García-Sierra F, Hauw JJ, Duyckaerts C, Wischik CM, Luna-Muñoz J, Mena R. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old. Acta Neuropathologica. 2000;100(1):29–35. PubMed

Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 1986;83(11):4044–4048. PubMed PMC

Mondragón-Rodríguez S, Basurto-Islas G, Santa-Maria I, et al. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease. International Journal of Experimental Pathology. 2008;89(2):81–90. PubMed PMC

Saito M, Chakraborty G, Mao RF, Paik SM, Vadasz C, Saito M. Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain. Neurochemical Research. 2010;35(4):651–659. PubMed PMC

Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer’s disease brain. Neurobiology of Disease. 2002;11(2):341–354. PubMed

Zhang Q, Zhang X, Sun A. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Acta Neuropathologica. 2009;117(6):687–697. PubMed

Cohen TJ, Guo JL, Hurtado DE, et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nature Communications. 2011;2(1, article 252) PubMed PMC

Irwin DJ, Cohen TJ, Grossman M, et al. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain. 2012;135(3):807–818. PubMed PMC

Choudhary C, Kumar C, Gnad F, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834–840. PubMed

Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes and Development. 2000;14(13):1553–1577. PubMed

Haigis MC, Guarente LP. Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction. Genes and Development. 2006;20(21):2913–2921. PubMed

Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochemical Journal. 2007;404(1):1–13. PubMed PMC

Gan L, Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron. 2008;58(1):10–14. PubMed PMC

Julien C, Tremblay C, Émond V, et al. Sirtuin 1 reduction parallels the accumulation of tau in alzheimer disease. Journal of Neuropathology and Experimental Neurology. 2009;68(1):48–58. PubMed PMC

Donmez G, Wang D, Cohen DE, Guarente L. SIRT1 suppresses β-amyloid production by activating the α-secretase gene ADAM10. Cell. 2010;142(2):320–332. PubMed PMC

Ruben GC, Iqbal K, Grundke-Iqbal I, Wisniewski HM, Ciardelli TL, Johnson JE. The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer. The Journal of Biological Chemistry. 1991;266(32):22019–22027. PubMed

Von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E. Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(10):5129–5134. PubMed PMC

Arrasate M, Pérez M, Armas-Portela R, Ávila J. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Letters. 1999;446(1):199–202. PubMed

Watanabe A, Takio K, Ihara Y. Deamidation and isoaspartate formation in smeared tau in paired helical filaments: unusual properties of the microtubule-binding domain of tau. The Journal of Biological Chemistry. 1999;274(11):7368–7378. PubMed

Crowther RA, Olesen OF, Jakes R, Goedert M. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer’s disease. FEBS Letters. 1992;309(2):199–202. PubMed

Pérez M, Valpuesta JM, Medina M, Montejo De Garcini E, Avila J. Polymerization of τ into filaments in the presence of heparin: the minimal sequence required for τ-τ interaction. Journal of Neurochemistry. 1996;67(3):1183–1190. PubMed

Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. 1996;383(6600):550–553. PubMed

Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Letters. 1996;399(3):344–349. PubMed

Wilson DM, Binder LI. Free fatty acids stimulate the polymerization of tau and amyloid β peptides: in vitro evidence for a common effector of pathogenesis in Alzheimer’s disease. American Journal of Pathology. 1997;150(6):2181–2195. PubMed PMC

Barghorn S, Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry. 2002;41(50):14885–14896. PubMed

Gamblin TC, Berry RW, Binder LI. Tau polymerization: role of the amino terminus. Biochemistry. 2003;42(7):2252–2257. PubMed

Kuret J, Chirita CN, Congdon EE, et al. Pathways of tau fibrillization. Biochimica et Biophysica Acta. 2005;1739(2):167–178. PubMed

King ME, Gamblin TC, Kuret J, Binder LI. Differential assembly of human tau isoforms in the presence of arachidonic acid. Journal of Neurochemistry. 2000;74(4):1749–1757. PubMed

Patterson KR, Remmers C, Fu Y, et al. Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease. The Journal of Biological Chemistry. 2011;286(26):23063–23076. PubMed PMC

Santacruz K, Lewis J, Spires T, et al. Medicine: tau suppression in a neurodegenerative mouse model improves memory function. Science. 2005;309(5733):476–481. PubMed PMC

Sydow A, Van Der Jeugd A, Zheng F, et al. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant. Journal of Neuroscience. 2011;31(7):2511–2525. PubMed PMC

Berger Z, Roder H, Hanna A, et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. Journal of Neuroscience. 2007;27(14):3650–3662. PubMed PMC

Wischik CM, Novak M, Thogersen HC, et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 1988;85(12):4506–4510. PubMed PMC

Novak M, Kabat J, Wischik CM. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer’s disease paired helical filament. The EMBO Journal. 1993;12(1):365–370. PubMed PMC

Mena R, Edwards PC, Harrington CR, Mukaetova-Ladinska EB, Wischik CM. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer’s disease. Acta Neuropathologica. 1996;91(6):633–641. PubMed

García-Sierra F, Wischik CM, Harrington CR, Luna-Muñoz J, Mena R. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer’s disease. Journal of Chemical Neuroanatomy. 2001;22(1-2):65–77. PubMed

Abraha A, Ghoshal N, Gamblin TC, et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer’s disease. Journal of Cell Science. 2000;113(21):3737–3745. PubMed

Rohn TT, Rissman RA, Head E, Cotman CW. Caspase activation in the Alzheimer’s disease brain: tortuous and torturous. Drug News and Perspectives. 2002;15(9):549–557. PubMed

De La Monte SM, Sohn YK, Wands JR. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer’s disease. Journal of the Neurological Sciences. 1997;152(1):73–83. PubMed

Stadelmann C, Deckwerth TL, Srinivasan A, et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease: evidence for apoptotic cell death. American Journal of Pathology. 1999;155(5):1459–1466. PubMed PMC

Rohn TT, Head E, Su JH, et al. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer’s disease. American Journal of Pathology. 2001;158(1):189–198. PubMed PMC

Nagy Z, Esiri MM. Apoptosis-related protein expression in the hippocampus in Alzheimer’s disease. Neurobiology of Aging. 1997;18(6):565–571. PubMed

Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer’s disease. American Journal of Pathology. 2004;165(2):523–531. PubMed PMC

Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW. Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology. Brain Research. 2001;898(2):350–357. PubMed

Cryns V, Yuan J. Proteases to die for. Genes and Development. 1998;12(11):1551–1570. PubMed

Gervais FG, Xu D, Robertson GS, et al. Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell. 1999;97(3):395–406. PubMed

Smale G, Nichols NR, Brady DR, Finch CE, Horton WE. Evidence for apoptotic cell death in Alzheimer’s disease. Experimental Neurology. 1995;133(2):225–230. PubMed

Rissman RA, Poon WW, Blurton-Jones M, et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. The Journal of Clinical Investigation. 2004;114(1):121–130. PubMed PMC

Cotman CW, Poon WW, Rissman RA, Blurton-Jones M. The role of caspase cleavage of tau in Alzheimer disease neuropathology. Journal of Neuropathology and Experimental Neurology. 2005;64(2):104–112. PubMed

Berry RW, Abraha A, Lagalwar S, et al. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry. 2003;42(27):8325–8331. PubMed

Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, et al. Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease. Neurobiology of Aging. 2005;26(7):1015–1022. PubMed

Guillozet-Bongaarts AL, Cahill ME, Cryns VL, Reynolds MR, Berry RW, Binder LI. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. Journal of Neurochemistry. 2006;97(4):1005–1014. PubMed

Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, et al. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer’s disease. Journal of Neuroscience. 2004;24(36):7895–7902. PubMed PMC

Bandyopadhyay B, Li G, Yin H, Kuret J. Tau aggregation and toxicity in a cell culture model of tauopathy. The Journal of Biological Chemistry. 2007;282(22):16454–16464. PubMed

Canu N, Dus L, Barbato C, et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. Journal of Neuroscience. 1998;18(18):7061–7074. PubMed PMC

Fasulo L, Ovecka M, Kabat J, Bradbury A, Novak M, Cattaneo A. Overexpression of Alzheimer’s PHF core tau fragments: implications for the tau truncation hypothesis. Alzheimer’s Research. 1996;2(5):195–200.

Fasulo L, Ugolini G, Visintin M, et al. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. Journal of Neurochemistry. 2000;75(2):624–633. PubMed

Fasulo L, Ugolini G, Cattaneo A. Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K. Journal of Alzheimer’s Disease. 2005;7(1):3–13. PubMed

Chun W, Johnson GVW. The role of tau phosphorylation and cleavage in neuronal cell death. Frontiers in Bioscience. 2007;12(2):733–756. PubMed

Matthews-Roberson TA, Quintanilla RA, Ding H, Johnson GVW. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Research. 2008;1234(C):206–212. PubMed PMC

Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnsion GVW. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of alzheimer disease. The Journal of Biological Chemistry. 2009;284(28):18754–18766. PubMed PMC

Quintanilla RA, Dolan PJ, Jin YN, Johnson GVW. Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiology of Aging. 2012;33(3):619.e25–619.e35. PubMed PMC

Filipcik P, Cente M, Krajciova G, Vanicky I, Novak M. Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration. Cellular and Molecular Neurobiology. 2009;29(6-7):895–900. PubMed PMC

Delobel P, Lavenir I, Fraser G, et al. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. American Journal of Pathology. 2008;172(1):123–131. PubMed PMC

De Calignon A, Fox LM, Pitstick R, et al. Caspase activation precedes and leads to tangles. Nature. 2010;464(7292):1201–1204. PubMed PMC

Koson P, Zilka N, Kovac A, et al. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. European Journal of Neuroscience. 2008;28(2):239–246. PubMed

Cente M, Filipcik P, Pevalova M, Novak M. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. European Journal of Neuroscience. 2006;24(4):1085–1090. PubMed

McMillan PJ, Kraemer BC, Robinson L, Leverenz JB, Raskind M, Schellenberg G. Truncation of tau at E391 promotes early pathologic changes in transgenic mice. Journal of Neuropathology and Experimental Neurology. 2011;70(11):1006–1019. PubMed PMC

Basurto-Islas G, Luna-Muñoz J, Guillozet-Bongaarts AL, Binder LI, Mena R, García-Sierra F. Accumulation of aspartic acid421- and glutamic acid 391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 2008;67(5):470–483. PubMed PMC

Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica. 1991;82(4):239–259. PubMed

García-Sierra F, Jarero-Basulto JJ, Kristofikova Z, Majer E, Binder LI, Ripova D. Ubiquitin is associated with early truncation of tau protein at aspartic acid421 during the maturation of neurofibrillary tangles in Alzheimer's disease. Brain Pathology. 2012;22(2):240–250. PubMed PMC

García-Sierra F, Mondragón-Rodríguez S, Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer’s disease. Journal of Alzheimer’s Disease. 2008;14(4):401–409. PubMed

Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases

Heart failure and Alzheimer's disease

Overlooked Alzheimer's smoking gun?